1. Vitamin C Suppresses Pancreatic Carcinogenesis through the Inhibition of Both Glucose Metabolism and Wnt Signaling
   Ji Hye Kim et al, 2022, International Journal of Molecular Sciences CrossRef
2. DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
   Zhenhai Zhang et al, 2022, Frontiers in Oncology CrossRef
3. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
   Daniel Massó-Vallés et al, 2022, Cancer Research Communications CrossRef
4. DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis
   Fei Han et al, 2023, Cell Cycle CrossRef
5. Enhancement of in-vivo cellular uptake of Coenzyme Q10 using saponin derivatives in rTALAP transgenic mice model
   Burcu Uner et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
6. High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
   Pulin Li et al, 2022, Journal of Inflammation Research CrossRef
7. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
   Xiaoyan Fan et al, 2022, Frontiers in Genetics CrossRef
8. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
   Xinyang Huang et al, 2022, Frontiers in Oncology CrossRef
9. DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37
   Hui Xiong et al, 2023, Molecular Medicine Reports CrossRef